Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Antidepressant treatment and cultural differences--a survey of the attitudes of physicians and patients in Sweden and Turkey.

Wade AG, Johnson PC, McConnachie A.

BMC Fam Pract. 2010 Nov 26;11:93. doi: 10.1186/1471-2296-11-93.

2.

[Results of the French cohort of the European observational study FINDER: quality of life of patients treated with antidepressants].

Dantchev N, Tcherny-Lessenot S, Picard H, Baraille L, Quail D.

Encephale. 2013 Apr;39(2):101-8. doi: 10.1016/j.encep.2012.06.006. Epub 2012 Aug 22. French.

PMID:
23095580
3.

Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment.

Demyttenaere K, Enzlin P, Dewé W, Boulanger B, De Bie J, De Troyer W, Mesters P.

J Clin Psychiatry. 2001;62 Suppl 22:34-7.

4.

[Antidepressants consumption in the global population in France].

Olié JP, Elomari F, Spadone C, Lépine JP.

Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7. French.

PMID:
12386542
5.

[Clinical and therapeutic characteristics of social phobia in French psychiatry (Phoenix study)].

Pélissolo A, Huron C, Fanget F, Servant D, Stiti S, Richard-Berthe C, Boyer P.

Encephale. 2006 Jan-Feb;32(1 Pt 1):106-12. French.

PMID:
16633297
6.

Are there detectable differences in quality of care or outcome of depression across primary care providers?

Katon W, Rutter CM, Lin E, Simon G, Von Korff M, Bush T, Walker E, Ludman E.

Med Care. 2000 Jun;38(6):552-61.

PMID:
10843308
7.
8.

Clinical Outcomes in Measurement-based Treatment (Comet): a trial of depression monitoring and feedback to primary care physicians.

Yeung AS, Jing Y, Brenneman SK, Chang TE, Baer L, Hebden T, Kalsekar I, McQuade RD, Kurlander J, Siebenaler J, Fava M.

Depress Anxiety. 2012 Oct;29(10):865-73. doi: 10.1002/da.21983. Epub 2012 Jul 16.

PMID:
22807244
9.

The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM.

J Clin Psychiatry. 2004 Apr;65(4):521-30.

PMID:
15119915
10.

Trait anxiety and defensive functioning in relation to antidepressant treatment outcome.

Sukul YR, Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA.

Psychopathology. 2009;42(6):387-93. doi: 10.1159/000241194. Epub 2009 Sep 24.

PMID:
19776669
11.

Patients' perceptions and illness severity at start of antidepressant treatment in general practice.

van Geffen EC, Heerdink ER, Hugtenburg JG, Siero FW, Egberts AC, van Hulten R.

Int J Pharm Pract. 2010 Aug;18(4):217-25. doi: 10.1111/j.2042-7174.2010.00035.x.

PMID:
20636673
13.

Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.

Revicki DA, Simon GE, Chan K, Katon W, Heiligenstein J.

J Fam Pract. 1998 Dec;47(6):446-52.

PMID:
9866670
14.
15.

Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.

Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, Baylé FJ.

J Clin Psychiatry. 2010 Feb;71(2):109-20. doi: 10.4088/JCP.09m05347blu.

PMID:
20193645
16.

Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide.

Pini S, Amador XF, Dell'Osso L, Baldini Rossi N, Cassano P, Savino M, Cassano GB.

Int Clin Psychopharmacol. 2003 Jan;18(1):15-21.

PMID:
12490770
17.

Physical comorbidity and 12-week treatment outcomes in Korean patients with depressive disorders: the CRESCEND study.

Kim JM, Stewart R, Bae KY, Yang SJ, Yoon JS, Jung SW, Lee MS, Yim HW, Jun TY.

J Psychosom Res. 2011 Nov;71(5):311-8. doi: 10.1016/j.jpsychores.2011.05.001. Epub 2011 Jun 26.

PMID:
21999974
18.

Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine.

Simon GE, Heiligenstein JH, Grothaus L, Katon W, Revicki D.

J Clin Psychiatry. 1998 Feb;59(2):49-55.

PMID:
9501885
19.

Appropriateness of antidepressant prescribing: an observational study in a Scottish primary-care setting.

Cameron IM, Lawton K, Reid IC.

Br J Gen Pract. 2009 Sep;59(566):644-9. doi: 10.3399/bjgp09X454061.

20.

Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.

Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN.

Depress Anxiety. 2008;25(7):E1-11.

PMID:
17587217

Supplemental Content

Support Center